Pfizer's sale of Indian animal health unit facilitates global business review
This article was originally published in Scrip
Executive Summary
Pfizer's Indian arm is divesting its animal health division to a fully owned subsidiary for a consideration of about Rs4.4 billion ($89.7 million). The move is part of an "internal re-organisation" that aims to give Pfizer the "broadest possible" flexibility to pursue a range of possible future transactions as it reviews strategic alternatives for its global animal health business.